cjc 1295 ipamorelin and tirzepatide 2X Blend CJC-1295 / Difference between tirzepatide and retatrutide:

Newer studies show that diabetes is responsible for the derangement of the antioxidant capability of body cells

It increases your overall antioxidant defense, a task that can never be accomplished just with one substance

Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S , Zhang H, Cao L, Ajani JA, Xu XC

and Bowry, V.W., J

Retatrutides ~24.2% (48 wk, 12 mg monotherapy) and cagrilintides ~10.8% (26 wk, 4.5 mg monotherapy) differ in duration and dose, and cagrilintides strongest data are combination (CagriSema) data

Some growth hormone peptides are researched for weight gain (bulking), but AOD9604 is a fragment that eliminates this effect